Top headlines: Govt plans IDBI sale; chief economist Gopinath to leave IMF

India's drug regulator is examining recommendation by experts for approving Bharat Biotech's Covaxin for children. More in top headlines this morning.

India’s drug regulator is examining the recommendation by the expert panel for the approval for Bharat Biotech’s Covaxin for children. The government will seek buyers for IDBI Bank and inform them about the broad contours of the strategic disinvestment.

More on those stories in our top headlines this morning.

Bharat Biotech's Covaxin roll-out for children likely in phases

The approval for Bharat Biotech’s Covaxin for use in children as young as two years may be some time away with India considering a phased roll-out of the vaccine for them. India’s drug regulator is carefully examining the recommendation by the